Logo image of BOMN

BOSTON OMAHA CORP-CL A (BOMN) Stock Fundamental Analysis

USA - NYSE:BOMN - Common Stock

25.76
-0.32 (-1.23%)
Last: 2/18/2022, 8:04:01 PM
25.76
0 (0%)
After Hours: 2/18/2022, 8:04:01 PM
Fundamental Rating

3

Taking everything into account, BOMN scores 3 out of 10 in our fundamental rating. BOMN was compared to 100 industry peers in the Media industry. BOMN may be in some trouble as it scores bad on both profitability and health. BOMN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BOMN had positive earnings in the past year.
BOMN Yearly Net Income VS EBIT VS OCF VS FCFBOMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 10.83%
ROE 16.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BOMN Yearly ROA, ROE, ROICBOMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -1 -2 -3 -4 -5

1.3 Margins

Industry RankSector Rank
OM -13.82%
PM (TTM) 159.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BOMN Yearly Profit, Operating, Gross MarginsBOMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

BOMN has more shares outstanding than it did 1 year ago.
BOMN has a better debt/assets ratio than last year.
BOMN Yearly Shares OutstandingBOMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M 25M
BOMN Yearly Total Debt VS Total AssetsBOMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 200M 400M 600M

2.2 Solvency

BOMN has an Altman-Z score of 2.31. This is not the best score and indicates that BOMN is in the grey zone with still only limited risk for bankruptcy at the moment.
BOMN has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.31
ROIC/WACCN/A
WACCN/A
BOMN Yearly LT Debt VS Equity VS FCFBOMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 100M 200M 300M

2.3 Liquidity

BOMN has a Current Ratio of 11.96. This indicates that BOMN is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 11.96 indicates that BOMN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 11.96
Quick Ratio 11.96
BOMN Yearly Current Assets VS Current LiabilitesBOMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 100M 200M 300M

7

3. Growth

3.1 Past

BOMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 613.83%, which is quite impressive.
Looking at the last year, BOMN shows a quite strong growth in Revenue. The Revenue has grown by 15.90% in the last year.
Measured over the past years, BOMN shows a very strong growth in Revenue. The Revenue has been growing by 129.40% on average per year.
EPS 1Y (TTM)613.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-784.62%
Revenue 1Y (TTM)15.9%
Revenue growth 3Y71.87%
Revenue growth 5Y129.4%
Sales Q2Q%24.88%

3.2 Future

Based on estimates for the next years, BOMN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.61% on average per year.
Based on estimates for the next years, BOMN will show a quite strong growth in Revenue. The Revenue will grow by 10.23% on average per year.
EPS Next Y493.44%
EPS Next 2Y42.58%
EPS Next 3Y29.34%
EPS Next 5Y24.61%
Revenue Next Year22.28%
Revenue Next 2Y15.24%
Revenue Next 3Y12.52%
Revenue Next 5Y10.23%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BOMN Yearly Revenue VS EstimatesBOMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BOMN Yearly EPS VS EstimatesBOMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 1 2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.00, the valuation of BOMN can be described as reasonable.
BOMN is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
BOMN is valuated quite expensively with a Price/Forward Earnings ratio of 1262.75.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, BOMN is valued quite expensively.
Industry RankSector Rank
PE 8
Fwd PE 1262.75
BOMN Price Earnings VS Forward Price EarningsBOMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 171.72
BOMN Per share dataBOMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BOMN's earnings are expected to grow with 29.34% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y42.58%
EPS Next 3Y29.34%

0

5. Dividend

5.1 Amount

BOMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BOSTON OMAHA CORP-CL A

NYSE:BOMN (2/18/2022, 8:04:01 PM)

After market: 25.76 0 (0%)

25.76

-0.32 (-1.23%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners67.32%
Inst Owner Change1.78%
Ins Owners41.02%
Ins Owner Change0%
Market Cap763.78M
Analysts82.5
Price Target42.33 (64.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8
Fwd PE 1262.75
P/S 14.38
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB N/A
EV/EBITDA 171.72
EPS(TTM)3.22
EY12.5%
EPS(NY)0.02
Fwd EY0.08%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.79
BVpS16.98
TBVpSN/A
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.83%
ROE 16.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -13.82%
PM (TTM) 159.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.96
Quick Ratio 11.96
Altman-Z 2.31
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)613.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-784.62%
EPS Next Y493.44%
EPS Next 2Y42.58%
EPS Next 3Y29.34%
EPS Next 5Y24.61%
Revenue 1Y (TTM)15.9%
Revenue growth 3Y71.87%
Revenue growth 5Y129.4%
Sales Q2Q%24.88%
Revenue Next Year22.28%
Revenue Next 2Y15.24%
Revenue Next 3Y12.52%
Revenue Next 5Y10.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A